🔴 Eupraxia Pharmaceuticals is trading 5% down in after-hours trading with no confirmed catalyst

Eupraxia Pharmaceuticals is trading 5.19% down in after-hours trading at $6.38, after falling from the August 21 regular-session close of $6.73; the catalyst remains unconfirmed.

• Searches found no new company-specific announcement, earnings release, regulatory action, or analyst move on August 21.
• Latest notable updates were August 11 second-quarter results and August 13 RESOLVE trial data, both preceding the decline.
• Broader markets finished higher, so the decline does not clearly track index-wide sentiment.